| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.03 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.03 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |